Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Randi Y. Leavitt
Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults
Clinical and Vaccine Immunology
Medicine
Immunology
Allergy
Clinical Biochemistry
Microbiology
Wegenerʼs Granulomatosis
Current Opinion in Rheumatology
Rheumatology
Related publications
Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine
Retrovirology
Virology
Infectious Diseases
Contribution of Virus-Like Particles to the Immunogenicity of Human Immunodeficiency Virus Type 1 Gag-Derived Vaccines in Mice
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
The Safety and Immunogenicity of Two Novel Live Attenuated Monovalent (Serotype 2) Oral Poliovirus Vaccines in Healthy Adults: A Double-Blind, Single-Centre Phase 1 Study
The Lancet
Medicine
Interactions of Single and Combined Human Immunodeficiency Virus Type 1 (HIV-1) DNA Vaccines
Virology
Virology
Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Gag Gene
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 Gag Gene
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Safety and Pharmacokinetics of Abacavir (1592U89) Following Oral Administration of Escalating Single Doses in Human Immunodeficiency Virus Type 1-Infected Adults
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Safety, Pharmacokinetics, and Immunogenicity of the Combination of the Broadly Neutralizing Anti-Hiv-1 Antibodies 3BNC117 and 10-1074 in Healthy Adults: A Randomized, Phase 1 Study
PLoS ONE
Multidisciplinary